Fenofibrate Tablets
Abbott Laboratories
Site Map | Contact Us
In addition to LDL-C
Framingham Heart Study: Relationship of elevated TG and risk for CHD
Relative risk of CHD by TG (1)
Relative risk of CHD by TG

Objective: To examine evidence from the Framingham Heart Study as it relates to elevated triglycerides and risk for CHD.

General summary: The Framingham Heart Study was started in 1948. A mostly random sample of 5,209 respondents was selected from the 10,000 men and women in Framingham who were aged 30-60 years. Of the random sample, 5,127 were free of clinically overt disease at entry and formed the prospective cohort.

  • In the univariate analysis, the Framingham heart Study found a simple linear relation between serum triglycerides and the subsequent development of CAD. This was statistically significant in all correlations in women but only in the 30-year data among the men.
  • Relative risk of coronary artery disease (CHD) by serum triglyceride (sf 20-400) levels in men and women (30-year follow-up).

    The independent effect of raising HDL-C or lowering TG on the risk of cardiovascular morbidity and mortality has not been determined. (2)

Framingham Heart Study: Relationship of HDL-C, LDL-C and risk for CHD

Risk of CHD by HDL-C vs LDL-C (3)
Risk of CHD by HDL-C vs LDL-5

Objective: To examine the use of blood lipids in predicting CAD with the aim of determining people who may need lowering of blood lipids by diet or drugs.

General summary: The Framingham Heart Study was started in 1948. A mostly random sample of 5,209 respondents was selected from the 10,000 men and women in Framingham who were aged 30-60 years. Of the random sample, 5,127 were free of clinically overt disease at entry and formed the prospective cohort.

  • The Framingham Heart Study showed that an LDL cholesterol level of 100 mg/dL with an HDL cholesterol of 25 mg/dL had the same risk for CAD as an LDL cholesterol level of 220 mg/dL with an HDL cholesterol of 45 mg/dL.
  • Risk of CAD in men aged 50 to 70 years according to HDL-C and LDL-C over 4 years of follow-up in the Framingham Heart Study.

    The independent effect of raising HDL-C or lowering TG on the risk of cardiovascular morbidity and mortality has not been determined (2).

References

  1. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol. 1992;70:3H-9H.
  2. TriCor tablets package insert, Abbott Laboratories.
  3. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-The Framingham Heart Study. Can J Cardiol. 1988;4:5A-10A.
06H-030-Q590-5